HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells.

Abstract
Type I IFNs are known to inhibit tumor cell growth and stimulate the immune system. However, little is known of the mechanism of type I IFN-induced apoptosis in human cancer cells. In this study, we have IFN-beta treatment of a human colorectal cell line (KM12L4) and a resistant clone of this cell line, L4RIFN. We demonstrate the induction of apoptosis in the parent cell line. This process was associated with the induction of the Jak-Stat signaling pathway, induction of the proapoptotic mediator tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and activation of procaspase-3, -8, -9, and -10. Additionally, we evaluated the role of Stat1 in mediating IFN-beta induction of these proapoptotic signals in a fibrosarcoma cell line (2ftgh) and a Stat1-deficient clone (U3A). Our results demonstrate that IFN-beta induction of apoptosis and the induction of proapoptotic mediator TRAIL is Stat1 dependent. Evaluation of a stable transfectant of the KM12L4 cell line expressing c-FLIP supports the role of TRAIL and the cell-surface death signaling pathways in IFN-beta induction of apoptosis. Studies evaluating the TRAIL promoter indicate induction of TRAIL promoter activity by IFN-beta. These results may represent a novel pathway by which IFN-beta may induce therapeutic effects.
AuthorsEugene A Choi, Hanqin Lei, David J Maron, James M Wilson, James Barsoum, Douglas L Fraker, Wafik S El-Deiry, Francis R Spitz
JournalCancer research (Cancer Res) Vol. 63 Issue 17 Pg. 5299-307 (Sep 01 2003) ISSN: 0008-5472 [Print] United States
PMID14500361 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Apoptosis Regulatory Proteins
  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • CFLAR protein, human
  • Carrier Proteins
  • Caspase Inhibitors
  • DNA-Binding Proteins
  • Interferon Type I
  • Intracellular Signaling Peptides and Proteins
  • Isoenzymes
  • Membrane Glycoproteins
  • Recombinant Proteins
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • TNF-Related Apoptosis-Inducing Ligand
  • TNFSF10 protein, human
  • Trans-Activators
  • Tumor Necrosis Factor-alpha
  • Caspases
Topics
  • Adenocarcinoma (drug therapy, metabolism, pathology)
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects, physiology)
  • Apoptosis Regulatory Proteins
  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • Carrier Proteins (biosynthesis)
  • Caspase Inhibitors
  • Caspases (metabolism)
  • Colorectal Neoplasms (drug therapy, metabolism, pathology)
  • DNA-Binding Proteins (physiology)
  • Enzyme Activation (drug effects)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Interferon Type I (pharmacology)
  • Intracellular Signaling Peptides and Proteins
  • Isoenzymes (antagonists & inhibitors, metabolism)
  • Membrane Glycoproteins (biosynthesis, genetics)
  • Promoter Regions, Genetic (drug effects)
  • Recombinant Proteins
  • STAT1 Transcription Factor
  • Signal Transduction (drug effects, physiology)
  • TNF-Related Apoptosis-Inducing Ligand
  • Trans-Activators (physiology)
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: